These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36057043)

  • 1. Lower cyst fluid carcinoembryonic antigen cutoff is helpful in the differential diagnosis of mucinous versus non-mucinous pancreatic cysts.
    Sharma RK; Bush N; Rana SS; Srinivasan R; Nada R; Gupta R; Rana S; Singh T
    Indian J Gastroenterol; 2022 Aug; 41(4):397-404. PubMed ID: 36057043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
    Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
    Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.
    Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR
    Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.
    Faias S; Duarte M; Albuquerque C; da Silva JP; Fonseca R; Roque R; Dias Pereira A; Chaves P; Cravo M
    Dig Dis Sci; 2018 Sep; 63(9):2351-2361. PubMed ID: 29796909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the RAS pathway through uncommon BRAF mutations in mucinous pancreatic cysts without KRAS mutation.
    Ren R; Krishna SG; Chen W; Frankel WL; Shen R; Zhao W; Avenarius MR; Garee J; Caruthers S; Jones D
    Mod Pathol; 2021 Feb; 34(2):438-444. PubMed ID: 32792597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts.
    Cizginer S; Turner BG; Bilge AR; Karaca C; Pitman MB; Brugge WR
    Pancreas; 2011 Oct; 40(7):1024-8. PubMed ID: 21775920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the performance of cyst fluid carcinoembryonic antigen as a diagnostic marker for pancreatic mucinous cysts: a comprehensive 20-year institutional review.
    Kwan MC; Pitman MB; Fernandez-Del Castillo C; Zhang ML
    Gut; 2024 Mar; 73(4):629-638. PubMed ID: 38195219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.
    Khalid A; Zahid M; Finkelstein SD; LeBlanc JK; Kaushik N; Ahmad N; Brugge WR; Edmundowicz SA; Hawes RH; McGrath KM
    Gastrointest Endosc; 2009 May; 69(6):1095-102. PubMed ID: 19152896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid.
    Sawhney MS; Devarajan S; O'Farrel P; Cury MS; Kundu R; Vollmer CM; Brown A; Chuttani R; Pleskow DK
    Gastrointest Endosc; 2009 May; 69(6):1106-10. PubMed ID: 19249035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms.
    Nagashio Y; Hijioka S; Mizuno N; Hara K; Imaoka H; Bhatia V; Niwa Y; Tajika M; Tanaka T; Ishihara M; Shimizu Y; Hosoda W; Yatabe Y; Yamao K
    Pancreatology; 2014; 14(6):503-9. PubMed ID: 25458668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of EUS-acquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions: a systematic review and meta-analysis.
    McCarty TR; Paleti S; Rustagi T
    Gastrointest Endosc; 2021 May; 93(5):1019-1033.e5. PubMed ID: 33359054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
    Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
    JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas.
    Schmitz D; Kazdal D; Allgäuer M; Trunk M; Vornhusen S; Nahm AM; Doll M; Weingärtner S; Endris V; Penzel R; Kirchner M; Brandt R; Neumann O; Sültmann H; Budczies J; Kienle P; Magdeburg R; Hetjens S; Schirmacher P; Bergmann F; Rudi J; Stenzinger A; Volckmar AL
    Genes Chromosomes Cancer; 2021 Jul; 60(7):489-497. PubMed ID: 33686791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts.
    Park WG; Mascarenhas R; Palaez-Luna M; Smyrk TC; O'Kane D; Clain JE; Levy MJ; Pearson RK; Petersen BT; Topazian MD; Vege SS; Chari ST
    Pancreas; 2011 Jan; 40(1):42-5. PubMed ID: 20966811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
    Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN
    Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excellent Accuracy of Glucose Level in Cystic Fluid for Diagnosis of Pancreatic Mucinous Cysts.
    Faias S; Pereira L; Roque R; Chaves P; Torres J; Cravo M; Pereira AD
    Dig Dis Sci; 2020 Jul; 65(7):2071-2078. PubMed ID: 31705344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyst fluid glucose: An alternative to carcinoembryonic antigen for pancreatic mucinous cysts.
    Lopes CV
    World J Gastroenterol; 2019 May; 25(19):2271-2278. PubMed ID: 31148899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.
    Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A
    Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance characteristics of molecular (DNA) analysis for the diagnosis of mucinous pancreatic cysts.
    Al-Haddad M; DeWitt J; Sherman S; Schmidt CM; LeBlanc JK; McHenry L; Coté G; El Chafic AH; Luz L; Stuart JS; Johnson CS; Klochan C; Imperiale TF
    Gastrointest Endosc; 2014 Jan; 79(1):79-87. PubMed ID: 23845445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience.
    Linder JD; Geenen JE; Catalano MF
    Gastrointest Endosc; 2006 Nov; 64(5):697-702. PubMed ID: 17055859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.